Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments

10.1371/journal.pone.0128360

Saved in:
Bibliographic Details
Main Authors: Wang D.D., Ma L., Wong M.P., Lee V.H.F., Yan H.
Other Authors: SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
Format: Article
Published: 2019
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/161510
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-161510
record_format dspace
spelling sg-nus-scholar.10635-1615102023-08-29T22:19:38Z Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments Wang D.D. Ma L. Wong M.P. Lee V.H.F. Yan H. SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH epidermal growth factor receptor epidermal growth factor receptor 2 epidermal growth factor receptor 3 erlotinib gefitinib scatter factor receptor somatomedin C receptor epidermal growth factor receptor epidermal growth factor receptor 3 ERBB3 protein, human erlotinib gefitinib mutant protein protein binding protein kinase inhibitor quinazoline derivative Article binding affinity dimerization female gene deletion heterodimerization human major clinical study male mutation non small cell lung cancer progression free survival protein function protein protein interaction signal transduction Carcinoma, Non-Small-Cell Lung chemistry disease free survival drug effects drug resistance genetics Lung Neoplasms metabolism molecular dynamics mutation protein multimerization regression analysis structural homology thermodynamics Carcinoma, Non-Small-Cell Lung Disease-Free Survival Drug Resistance, Neoplasm Erlotinib Hydrochloride Humans Lung Neoplasms Molecular Dynamics Simulation Mutant Proteins Mutation Protein Binding Protein Kinase Inhibitors Protein Multimerization Quinazolines Receptor, Epidermal Growth Factor Receptor, ErbB-3 Regression Analysis Signal Transduction Structural Homology, Protein Thermodynamics 10.1371/journal.pone.0128360 PLoS ONE 10 5 e0128360 2019-11-06T01:30:36Z 2019-11-06T01:30:36Z 2015 Article Wang D.D., Ma L., Wong M.P., Lee V.H.F., Yan H. (2015). Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments. PLoS ONE 10 (5) : e0128360. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0128360 19326203 https://scholarbank.nus.edu.sg/handle/10635/161510 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20191101
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic epidermal growth factor receptor
epidermal growth factor receptor 2
epidermal growth factor receptor 3
erlotinib
gefitinib
scatter factor receptor
somatomedin C receptor
epidermal growth factor receptor
epidermal growth factor receptor 3
ERBB3 protein, human
erlotinib
gefitinib
mutant protein
protein binding
protein kinase inhibitor
quinazoline derivative
Article
binding affinity
dimerization
female
gene deletion
heterodimerization
human
major clinical study
male
mutation
non small cell lung cancer
progression free survival
protein function
protein protein interaction
signal transduction
Carcinoma, Non-Small-Cell Lung
chemistry
disease free survival
drug effects
drug resistance
genetics
Lung Neoplasms
metabolism
molecular dynamics
mutation
protein multimerization
regression analysis
structural homology
thermodynamics
Carcinoma, Non-Small-Cell Lung
Disease-Free Survival
Drug Resistance, Neoplasm
Erlotinib Hydrochloride
Humans
Lung Neoplasms
Molecular Dynamics Simulation
Mutant Proteins
Mutation
Protein Binding
Protein Kinase Inhibitors
Protein Multimerization
Quinazolines
Receptor, Epidermal Growth Factor
Receptor, ErbB-3
Regression Analysis
Signal Transduction
Structural Homology, Protein
Thermodynamics
spellingShingle epidermal growth factor receptor
epidermal growth factor receptor 2
epidermal growth factor receptor 3
erlotinib
gefitinib
scatter factor receptor
somatomedin C receptor
epidermal growth factor receptor
epidermal growth factor receptor 3
ERBB3 protein, human
erlotinib
gefitinib
mutant protein
protein binding
protein kinase inhibitor
quinazoline derivative
Article
binding affinity
dimerization
female
gene deletion
heterodimerization
human
major clinical study
male
mutation
non small cell lung cancer
progression free survival
protein function
protein protein interaction
signal transduction
Carcinoma, Non-Small-Cell Lung
chemistry
disease free survival
drug effects
drug resistance
genetics
Lung Neoplasms
metabolism
molecular dynamics
mutation
protein multimerization
regression analysis
structural homology
thermodynamics
Carcinoma, Non-Small-Cell Lung
Disease-Free Survival
Drug Resistance, Neoplasm
Erlotinib Hydrochloride
Humans
Lung Neoplasms
Molecular Dynamics Simulation
Mutant Proteins
Mutation
Protein Binding
Protein Kinase Inhibitors
Protein Multimerization
Quinazolines
Receptor, Epidermal Growth Factor
Receptor, ErbB-3
Regression Analysis
Signal Transduction
Structural Homology, Protein
Thermodynamics
Wang D.D.
Ma L.
Wong M.P.
Lee V.H.F.
Yan H.
Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments
description 10.1371/journal.pone.0128360
author2 SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
author_facet SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
Wang D.D.
Ma L.
Wong M.P.
Lee V.H.F.
Yan H.
format Article
author Wang D.D.
Ma L.
Wong M.P.
Lee V.H.F.
Yan H.
author_sort Wang D.D.
title Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments
title_short Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments
title_full Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments
title_fullStr Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments
title_full_unstemmed Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments
title_sort contribution of egfr and erbb-3 heterodimerization to the egfr mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments
publishDate 2019
url https://scholarbank.nus.edu.sg/handle/10635/161510
_version_ 1778169205544189952